Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study.
CONCLUSIONS: The prevalence of MGUS in patients with HFpEF without hypertrophy was 3-fold that of the general population. There was no significant correlation between clinical outcomes and the presence of MGUS. Beta-blockers and ACEIs/ARBs reduced the composite of mortality and readmissions for HF in HFpEF patients. Hyperpotassemia was related to worse prognosis.
PMID: 32329041 [PubMed - as supplied by publisher]
Source: Cardiology Journal - Category: Cardiology Authors: Devesa Arbiol A, Rodríguez Olleros C, Kaçi X, Askari E, Camblor Blasco A, Pello Lázaro AM, Gómez Talavera S, Gómez Octavio J, Lapeña G, Navarro F, Tuñón J, Ibáñez B, Aceña Á Tags: Cardiol J Source Type: research